MARK2 and Alzheimer disease: Glycogen synthase kinase-3β (GSK3β), an ubiquitously expressed serine/threonine kinase, plays a key role in the pathogenesis of AD, influencing Tau phosphorylation, Aβ production, neurogenesis and synaptic function [42].